Instem Conference Series Delivers Value To Users Across The Globe
Instem Connects With Clients at Meetings in Europe, North America, China and Japan
CONSHOHOCKEN, PA – December 11, 2013 - -Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that its 2013 Instem International Conference Series (IIC) has been deemed another great success by clients.
The IIC is a key component of Instem's Customer Involvement Program (CIP), offering delegates an excellent opportunity to help shape Instem's solution roadmap, see new solutions under development and hear the latest news regarding product strategy. The IIC also provides excellent networking opportunities, enabling delegates to connect with their industry peers and key members of the Instem team, sharing best practice and learning opportunities.
During October a series of regional IIC meetings took place across the globe in Cheshire, UK, Philadelphia, USA and Beijing, China, with the final meeting taking place in November in Tokyo, Japan, hosted by CTC, Instem’s Japanese distributor.
The IIC meetings included a range of presentations delivered by members of the Instem team and client speakers from Astellas Pharma Inc., AstraZeneca, Bristol-Myers Squibb, MPI Research, Shanghai Institute of Materia Medica and WIL Research. The keynote address, delivered by David Cook, Associate Director Global Safety Assessment, AstraZeneca, discussed the benefits of collecting, analyzing and sharing data across the R&D continuum to deliver improved drug safety, a theme which underpinned many of the conference presentations.
SEND (Standard for Exchange of Nonclinical Data) was a hot topic at all 4 meetings and delegates appreciated the opportunity to learn more about this important standard and Instem’s range of widely deployed SEND solutions including submit™ and SENDView™. Delegates also had the opportunity to take part in a range of Spotlight Sessions – interactive breakout sessions featuring a range of solutions from Instem’s Study Workflow & Automation and Data Integration & Bioinformatics solution suites. In addition, the IIC offered plenty of networking opportunities as well as 1:1’s and Q&A sessions with Instem’s team of experts.
Julie Jones, Marketing Manager, Instem said "It was fantastic to connect with so many of our clients from across the globe. The IIC provides a great opportunity for us to further cement and strengthen our client relationships and it was pleasing to see such high levels of positive interaction and great customer feedback across the conference series.”
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600